Hypoimmune anti-CD19 chimeric antigen receptor T cells provide lasting tumor control in fully immunocompetent allogeneic humanized mice
Xiaomeng Hu(Huzhou University), Sonja Schrepfer(Cedars-Sinai Medical Center)
Cited by 81
Related Papers
Hypoimmune induced pluripotent stem cells survive long term in fully immunocompetent, allogeneic rhesus macaques
|Nature Biotechnology|2023|145
Hypoimmune induced pluripotent stem cell–derived cell therapeutics treat cardiovascular and pulmonary diseases in immunocompetent allogeneic mice
|Proceedings of the National Academy of Sciences|2021|53